Amazon isn't the problem. It's the other FAANG stocks. Adding Tesla to the S&P 500 just further highlights the high PEs and ridiculous market caps of many of these stocks. Microsoft and Google should get heir own acronym for big decently priced companies and let the rest of the FAANGs go down alone.

The S&P 500s metrics are getting worse and worse. I am willing to pay for bigger stocks but the inclusion of Tesla and other large cap stocks with marginal earnings and huge market caps really make me wonder about its future. Tesla is neither a new stock or a hyper growth stock yet trades at that with a high multiple and needed Space X to help keep it funded just a short while ago. The main issue is its cash flow and its not to recent terrible cash flow.

Sure its cash flow positive right now. But I wonder for how much longer. It regularly requires huge capital outlays. I'm for electric cars, just not paying such a huge market cap for it. At least it has a wad of Chinese cash and production to help keep it afloat for now.

It's 20 years later. The load of top companies in the S and P is natural progression and selection, especially since their goal is not to try to model it after the economy in any way such as Dow Jones Industrial tried to do. This way we can see as money amasses into the survivors which tend to be the ultra large stocks that grow through natural selection, takeovers, and monopolistic behaviors.

Silver may rise due to financial difficulties of some of the miners, otherwise forget the noise and expect prices to remain relatively flat.

Recent Cytodyn response on the Phase II trial.

www.youtube.com/watch

Some people were confused regarding the meaning of the results. Here is an article which clarifies the meaning of the outcomes.

insiderfinancial.com/.../180185/

Those buying Indexes or buying tech willy nilly will not benefit the same way as those who are being selective. A lot of tech is overvalued and seen as similar or equal to software and internet stocks but shouldn't be because they can't grow in a logarithmic fashion and aren't easily scalable.

Update:

www.globenewswire.com/.../...2-Covid-19-Trial.html

People should be looking at science not talking heads speculating. Look at the FDA and their results and companies. As many know, I'm hopeful and have shares in CYDY Cytodyne mainly for its Cancer treatment, but they are the first in line at stopping Covid from causing death via lung infections. Hopefully we will get results this week.

The science and the growth and passivization of Covid itself comes first before one can speculate on the winners in the stock market. Unless you are aware of the science useless statements mean little to nothing being its dependent on science and infection rates.

The secret for Covid times is not metrics but finding out which companies will thrive in these trying times. The successful ones will grow into these metrics. If they don't grow into them and replace the current companies they will face tough times, but that is a later story. This is why Index buying isn't the best strategy right now.